Director Shareholding

GlaxoSmithKline PLC 01 October 2004 Directors' Interests I give below details of changes in the directors' interests in the Ordinary Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 1 October 2004, the following non-executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company under the automatic share allocation arrangements for non-executive Directors for the period of service from 1 July to 30 September 2004, as listed below. Non Executive Director Ordinary Shares American Depository Shares (ADS) Sir Christopher Hogg 1,500 Sir Christopher Gent 1254.88009 Mr Lawrence Culp 125 Mr Crispin Davis 250 Sir Peter Job 250 Sir Deryck Maughan 125 Sir Ian Prosser 250 Dr Ronaldo Schmitz 250 Dr Lucy Shapiro 125 Sir Robert Wilson 250 At the same time the following non-executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company under the share election element of the share allocation arrangements for non-executive Directors for the period of service from 1 July to 30 September 2004, as listed below. Non Executive Director Ordinary Shares American Depositary Shares (ADS) Sir Christopher Hogg 3,137.2002 Mr Lawrence Culp 412.5602 Mr Crispin Davis 941.1601 Sir Peter Job 941.1601 Sir Deryck Maughan 548.5691 Sir Ian Prosser 470.58 Dr Ronaldo Schmitz 460.1227 The Company and the directors were informed of these allocations on 1 October 2004. S M Bicknell Company Secretary 1 October 2004 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings